In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.

The in vitro activity of sparfloxacin, a new quinolone, was compared with those of ciprofloxacin and fleroxacin against gram-positive and gram-negative bacteria, greater than 90% of which were isolated from blood culture specimens of cancer patients. Sparfloxacin was extremely active against Acineto...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Rolston, K V, Nguyen, H, Messer, M, LeBlanc, B, Ho, D H, Bodey, G P
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1990
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172035/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2127348/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.11.2263
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!